Been diagnosed with Classic B-Cell Follicular Lymphoma. On Friday I have my first treatment of Bendamustine and then...

LymphomaOctober 3, 2026Written by Navis AI

Understanding Your Bendamustine + Rituximab Treatment

I'm glad you're getting started with a well-established treatment plan. Let me help you understand what to expect and what these medications do.

What These Drugs Do

Bendamustine is a chemotherapy medication that damages cancer cell DNA, making it difficult for lymphoma cells to survive and divide.

Rituximab is a monoclonal antibody—think of it as a targeted protein that recognizes and attaches to CD20, a marker found on the surface of B cells (including your lymphoma cells). Once rituximab binds to these cells, it triggers your immune system to destroy them.

Together, this combination is one of the preferred first-line treatments for follicular lymphoma according to NCCN Guidelines, and has strong evidence supporting its effectiveness.

Tell us what’s going on with lymphoma. 2 free answers, then a free account.

Why the Hospital Admission & Fluid Management Matter

Your oncology team is being proactive by admitting you for:

  • IV hydration: Extra fluids help protect your kidneys from byproducts released when lymphoma cells break down (called tumor lysis syndrome, or TLS)
  • Kidney function monitoring: Blood tests track how well your kidneys are handling the treatment
  • Close observation: Your medical team can quickly address any side effects

This is standard and protective care—it's a sign your team is taking safety seriously.


What to Expect: Common Side Effects

During/immediately after treatment:

  • Fever, chills, or flu-like symptoms (very common with rituximab)
  • Nausea or vomiting
  • Fatigue
  • Low blood counts (which can cause weakness, increased infection risk, or bruising)

In the days/weeks following:

  • Continued fatigue (often the most bothersome side effect)
  • Hair loss (bendamustine can cause this)
  • Mouth sores
  • Diarrhea or constipation
  • Weakened immune system (increased infection risk)

Important: Most side effects are manageable with supportive medications. Your team will provide anti-nausea drugs, growth factors to boost blood counts, and other supportive care.


Real-World Patient Experiences

While I don't have access to specific patient testimonials in my current resources, I can tell you that bendamustine + rituximab is a well-tolerated regimen compared to older chemotherapy approaches. Many patients describe:

  • Manageable side effects with proper support
  • Fatigue as the most limiting factor (usually improves between cycles)
  • Good quality of life between treatment sessions
  • Significant relief when lymphoma responds to treatment

The fact that you're being admitted for monitoring suggests your team expects good tolerance with proper precautions.


Questions to Ask Your Oncology Team Before Friday

  1. About the treatment itself:

    • How many cycles of bendamustine + rituximab will I receive, and how far apart are they?
    • What's the expected timeline for seeing a response?
    • Will I need maintenance therapy after initial treatment?
  2. About side effects and management:

    • Which side effects are most common in YOUR specific situation?
    • What medications will you give me to prevent nausea, fever, or other side effects?
    • When should I call if I develop symptoms at home?
    • What's the plan if I have severe side effects?
  3. About monitoring:

    • How often will you check my blood counts and kidney function?
    • When will we do imaging to see if the lymphoma is responding?
    • What does a "good response" look like for my type of lymphoma?
  4. About daily life:

    • When can I return to normal activities?
    • Are there foods or activities I should avoid?
    • Can I work during treatment?
    • What precautions should I take regarding infection risk?
  5. About your specific case:

    • Why was bendamustine + rituximab chosen for me specifically?
    • Are there any biomarkers or test results that influenced this decision?
    • What's the expected outcome with this treatment?

Evidence Supporting Your Treatment Plan

According to NCCN Guidelines for Follicular Lymphoma, bendamustine + rituximab is a Category 1 preferred option for first-line treatment, based on strong clinical trial evidence showing:

  • High response rates
  • Durable remissions
  • Manageable side effect profile
  • Improved outcomes compared to older chemotherapy approaches

The NCCN Guidelines for Patients: Follicular Lymphoma specifically notes that this combination is one of several effective first-line options, and your team's choice reflects current best practices.


Practical Tips for Your Hospital Stay

  • Bring comfort items (phone charger, entertainment, comfortable clothes)
  • Ask about dietary restrictions or preferences
  • Request a list of emergency symptoms to watch for after discharge
  • Ask about support services (social work, nutrition, patient education)
  • Take notes during conversations with your care team
  • Don't hesitate to ask nurses questions—they have valuable experience

Moving Forward

Your proactive approach—asking questions and understanding your treatment—is excellent. Engaged patients tend to have better outcomes and catch side effects early. Your hospital admission is a sign your team is being thorough and cautious.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.


Sources cited:

  • NCCN Guidelines for Follicular Lymphoma (Version 3.2025)
  • NCCN Guidelines for Patients: Follicular Lymphoma (2024)

Your next question, already answered

Tap to keep going. 2 free answers, then a free account.

Ask Navis about your case

That answer is general. Ask about your specific situation. Answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Sources & medical oversight

Question asked:

I have been diagnosed with Classic B-Cell Follicular Lymphoma. On Friday I have my first treatment of Bendamustine and then Rituximab on Saturday. I am being admitted to the hospital so they can administer extra fluids and watch my kidney function. What are people’s experiences with these treatme...

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

More questions about Lymphoma